Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Don't stint on DMP (disease management programme) quality, warns German minister:

This article was originally published in Clinica

Executive Summary

The successful introduction of the disease management programmes (DMPs) is a test for the self-governing bodies of the German health service, says Klaus Kirchner, chairman of the health committee of the German lower house (Bundestag). Mr Kirchner said last week in Berlin, that "under no circumstances" should doctors associations or sickness funds attempt to introduce a diluted version of the DMPs, which are aimed at offering optimal treatment to the chronically ill. "The aim of the DMPs should be to provide a high standard of medical care with better quality and security for the patient and doctor. Any attempt to block this quality improvement is unacceptable," he said. Mr Kirchner added that, if any party failed to comply with the requirements of such programmes, they would be responsible for future demands for change to the health system.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel